Barclays ups CVS Health to Buy on positive margin outlook
CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst
Barclays upgraded CVS Health Inc (NYSE:CVS) on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage. Despite macroeconomic pressures impacting the retail pharmacy sector,
Key Takeaways A higher-than-anticipated report on consumer inflation sent U.S. equities lower at midday.Solar power company ...
The U.S. government on Thursday announced quality ratings for 2025 Medicare health and prescription drug plans, the first ...
Barclays analyst Andrew Mok CFA maintained a Buy rating on ... Mok CFA covers the Healthcare sector, focusing on stocks such as Centene, CVS Health, and Humana. The word on The Street in general ...
CVS Health is laying off nearly 3,000 "primarily corporate roles" in a cost-cutting move, the company confirmed to USA TODAY ...
In terms of liquidity and interest, the mean open interest for CVS Health options trades today is 5602.57 with a total volume ...
CVS Health, one of the biggest players in the battle to acquire physicians, is facing a possible split amid major financial struggles. In 2023, CVS Health spent $10.6 billion to acquire primary care ...
(Reuters) -CVS Health said on Tuesday it would lay off about 2,900 employees, representing less than 1% of its workforce, as ...
The drugstore chain's board has hired bankers to help review options for the company, including a potential breakup. Shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback